Simple formulations that fulfil healthcare needs
Global manufacturer of pharmaceutical excipients
and actives Roquette Pharma has'
pursued a commitment to customer satisfaction
through the development of products'
that meet the highest quality standards for healthcare.
Roquette Pharma is a global'
manufacturer of pharmaceutical'
excipients and actives. For over 30'
years, the firm has focused on customer'
satisfaction through developing products'
that meet the most stringent quality'
standards for the healthcare industries.'
Roquette Pharma continues to dedicate a'
large part of its resources to innovation, with'
the development of new excipients for'
unmet needs, along with associated services'
and innovative solutions. Throughout 2011,'
the company launched new ways of helping'
its clients create more valuable and'
successful products.
|
|
|
| |
KLEPTOSE® Linecaps
forms a flexible' adaptable amylose helix
that is freely' soluble in water.
|
Taste-masking technology
The bitter taste of medicines has always' been
an issue. Roquette Pharma's new' taste-masking
technology is applicable for a' wide range of
dosage forms including' liquids, chewable tablets,
orally disintegrating tablets and' suspensions.
This technology is a cost-effective solution for'
over-the-counter and nutraceutical/herbal products.
The technology also offers new perspectives in
developing'
new dosage forms for the paediatric market. KLEPTOSER'
Linecaps is a pea maltodextrin, which forms a
flexible'
adaptable amylose helix that is freely soluble
in water, while'
Amylose is capable of masking the bitter taste
of drugs by'
decreasing the overall amount of drug particles
exposed to'
the taste buds.
Scaling-up simulation technology
From design to manufacturing, Roquette Pharma
is committed'
to its clients' success. Its team of development
scientists and'
pharmacists enable an effective technical interface
between'
the pharmaceutical industry and the company.
There is an increasing need for expertise sharing
in the'
tablet field to guarantee seamless manufacturing'
development. Roquette Pharma can offer customised'
solutions for formulation development, including
the'
prediction of manufacturing settings on industrial
equipment'
to address compression simulation issues.
Roquette Pharma and the Institut de la Garonne
have'
pooled their expertise to provide a new high-predictive'
compression simulation service. This'
enables the optimisation of the client's'
choice of excipients (such as diluents,'
binders and lubricants), and the selection'
of the best tablet press. The customer will'
be able to:
- determine the critical tableting'
parameters for a given formula by simulating'
different tablet presses (for example, the'
influence of main compression force,'
precompression ratio and tableting speed)'
- maximise their choice of the best tablet'
press for a given formula'
- analyse and troubleshoot (such as'
capping and sticking).'
This service will be disclosed at CPhI'
2011 in Frankfurt on 25-27 October 2011'
at stand 42G24, Hall 4.2).
On-site assistance for film coating
Roquette Pharma's new film coating technologies
LYCOATR'
and ReadiLYCOATR offer great potential. Using
the natural'
inert polymer and the ready-to-use system for
fast aqueous'
film coating will save clients up to 50% in costs
and will'
reduce production time. On-site assistance, colour
matching'
and training are available online at www.readilycoat.com.
Continuous industrial investment
To be closer to the source of demand, Roquette
Pharma is'
constantly strengthening its worldwide presence
and'
continuously developing its capabilities in Europe,
the'
Americas and Asia.
The firm has recently completed an investment
in an'
injectable grade carbohydrate facility in France
to support the'
increasingly sophisticated demands of the injectable
industry'
in terms of quality and regulatory constraints.
It has also'
strengthened the supply chain through its US back-up'
carbohydrates production facility.
|
